Find clinical trials for Asthma in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near San Francisco, CA, USA:
This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...
Phase 2
San Jose, California, United States and 72 other locations
This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma....
Phase 1
San Francisco, California, United States and 3 other locations
and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroi...
Phase 2
San Jose, California, United States of America and 24 other locations
immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...
Phase 1
San Jose, California, United States of America and 12 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Napa, California, United States and 335 other locations
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...
Phase 2
San Jose, California, United States of America and 70 other locations
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...
Phase 2
Walnut Creek, California, United States and 101 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
San Jose, California, United States and 134 other locations
Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...
Phase 2
San Jose, California, United States and 14 other locations
PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...
Phase 2
Walnut Creek, California, United States and 136 other locations
Clinical trials
Research sites
Resources
Legal